← All organizations
First clinical trial
Feb 2, 2021Last known activity
Jan 8, 2024
Acquired by Sesen Bio → Carisma Therapeutics → Sesen Bio → Carisma Therapeutics → Sesen Bio → Carisma Therapeutics → Sesen Bio → Carisma Therapeutics → Sesen Bio → Carisma Therapeutics → Sesen Bio → Carisma Therapeutics → Sesen Bio → Carisma Therapeutics → Sesen Bio → Carisma Therapeutics → Sesen Bio → Carisma Therapeutics → Sesen Bio → Carisma Therapeutics → Sesen Bio → Carisma Therapeutics → Sesen Bio → Carisma Therapeutics → Sesen Bio on Sep 21, 2022
Timeline
Drugs by trial phase (6 distinct, 14 trials)
Subsidiaries (1 direct, 49 total across the full acquisition tree)
- Sesen Bio
- Carisma Therapeutics L2
- Viventia L2
- Viventia Biotech Inc. L2
- Sesen Bio L3
- Carisma Therapeutics L4
- Viventia L4
- Viventia Biotech Inc. L4
- Sesen Bio L5
- Carisma Therapeutics L6
- Viventia L6
- Viventia Biotech Inc. L6
- Sesen Bio L7
- Carisma Therapeutics L8
- Viventia L8
- Viventia Biotech Inc. L8
- Sesen Bio L9
- Carisma Therapeutics L10
- Viventia L10
- Viventia Biotech Inc. L10
- Sesen Bio L11
- Carisma Therapeutics L12
- Viventia L12
- Viventia Biotech Inc. L12
- Sesen Bio L13
- Carisma Therapeutics L14
- Viventia L14
- Viventia Biotech Inc. L14
- Sesen Bio L15
- Carisma Therapeutics L16
- Viventia L16
- Viventia Biotech Inc. L16
- Sesen Bio L17
- Carisma Therapeutics L18
- Viventia L18
- Viventia Biotech Inc. L18
- Sesen Bio L19
- Carisma Therapeutics L20
- Viventia L20
- Viventia Biotech Inc. L20
- Sesen Bio L21
- Carisma Therapeutics L22
- Viventia L22
- Viventia Biotech Inc. L22
- Sesen Bio L23
- Carisma Therapeutics L24
- Viventia L24
- Viventia Biotech Inc. L24
- Sesen Bio L25
Recent trials (3)
- NCT06254807Lead sponsorPhase 1Jan 8, 2024
- NCT04660929Lead sponsorPhase 1Feb 2, 2021
- NCT04660929Study directorPhase 1Feb 2, 2021
Details
- Founded
- Philadelphia, PA, US Jun 1, 2016
- Last known activity
- Jan 8, 2024